search icon

    Market Snapshot

    • S&P Futures

      3,819

    • Dow Futures

      30,822

    • Nasdaq Futures

      11,785

    blog search icon

    Aptevo Therapeutics Inc.

    (NASDAQ:APVO)

    $3.9

    $0.13

    3.45%

    Aptevo Therapeutics Inc. Chart

    APVO Stock Price Today

    Aptevo Therapeutics Inc. (APVO) stock rallied over 3.45% intraday to trade at $3.90 a share on NASDAQ. The stock opened with a gain of 11.43% at $3.88 and touched an intraday high of $4.15, rising 3.45% against the last close of $3.77. The stock went to a low of $3.8 during the session.

    Stock Snapshot

    $3.77

    Prev. Close

    19.5 Million

    Market Cap

    $3.8

    Day Low

    $3.88

    Open

    4.94 Million

    Number of Shares

    $4.15

    Day High

    -

    P/E ratio

    -6.17

    EPS (TTM)

    9.00

    Cash Flow per Share

    3.68

    Free Float in %

    1.49

    Book Value

    82,644

    Volume

    Aptevo Therapeutics Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-06$3.88$4.15$3.8$3.982,649
    2022-07-05$3.5$3.94$3.44$3.7787,900
    2022-07-01$3.6$3.68$3.48$3.5829,200
    2022-06-30$3.42$3.677$3.373$3.5868,500
    2022-06-29$3.43$3.62$3.43$3.5385,200
    2022-06-28$3.61$3.73$3.44$3.4885,600
    2022-06-27$3.78$3.86$3.6$3.6568,200
    2022-06-24$4.02$4.1$3.815$3.8851,100
    2022-06-23$3.96$4.19$3.795$4.0166,400
    2022-06-22$3.56$3.94$3.539$3.9136,400

    Contact Details

    2401 4th Avenue
    Suite 1050
    Seattle, WA 98121
    United States

    Webiste:APVO

    206 838 0500

    Company Information

    Employees-

    Beta6.12

    Sales or Revenue12.29 Million

    5Y Sales Change4.20%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndrome. The company's preclinical candidates also include ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers; and APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40. It also develoes APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

    Frequently Asked Questions

    icon

    What is the current Aptevo Therapeutics Inc. (APVO) stock price?

    Aptevo Therapeutics Inc. (NASDAQ: APVO) stock price is $3.9 as of the last check on Wednesday, July 6. During the trading session, APVO stock reached the peak price of $4.15 while $3.8 was the lowest point it dropped to.

    icon

    APVO's industry and sector of operation?

    The NASDAQ listed APVO is part of Biotechnology industry that operates in the broader Health Care sector. Aptevo Therapeutics Inc. , a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

    icon

    Who are the executives of APVO?

    Mr. Jeffrey G. Lamothe
    Sr. VP, CFO & Treasurer
    Mr. Marvin L. White
    Pres, CEO & Director
    Mr. Jeffrey G. Lamothe CA
    Exec. VP & CFO
    Ms. SoYoung Kwon J.D., LL.M.
    Sr. VP, Gen. Counsel, Corp. Affairs & HR

    icon

    What is the APVO stock price today?

    APVO stock traded closed the last session at $3.9, which is $0.13 or 3.45% lower than its previous close of $3.77. APVO's current trading price is 28.71% lower than its 52-week high of $22.50 where as its distance from 52-week low of 3.03% is -82.67%.

    icon

    How many employees does APVO have?

    Number of APVO employees currently stands at -. APVO operates from 2401 4th Avenue, Suite 1050, Seattle, WA 98121, United States.

    icon

    Link for APVO official website?

    Official Webiste of $APVO is: https://www.aptevotherapeutics.com

    icon

    How do I contact APVO?

    APVO could be contacted at APVO operates from 2401 4th Avenue, Suite 1050, Seattle, WA 98121, United States, or at phone #206 838 0500 and can also be accessed through its website.

    icon

    How many shares of APVO are traded daily?

    APVO stock volume for the day was 82,644 shares while in the previous session number of APVO shares traded was 82,649 . The average number of APVO shares traded daily for last 3 months was 95.67 Thousands.

    icon

    How much did APVO change today?

    The percentage change in APVO stock occurred in the recent session was 3.45% while the dollar amount for the price change in APVO stock was $0.13.

    icon

    What price range APVO stock been trading in?

    In the recent session, the day high for APVO stock was $4.15 while the low for APVO stock touched on the day was $3.8.

    icon

    What is the market cap of APVO currently?

    The market value of APVO currently stands at 19.5 Million with its latest stock price at $3.9 and 4.94 Million of its shares outstanding.